chr1-46405702-C-G
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001441.3(FAAH):āc.693C>Gā(p.Pro231=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00099 in 1,613,602 control chromosomes in the GnomAD database, including 14 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.0055 ( 9 hom., cov: 33)
Exomes š: 0.00052 ( 5 hom. )
Consequence
FAAH
NM_001441.3 synonymous
NM_001441.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -1.09
Genes affected
FAAH (HGNC:3553): (fatty acid amide hydrolase) This gene encodes a protein that is responsible for the hydrolysis of a number of primary and secondary fatty acid amides, including the neuromodulatory compounds anandamide and oleamide. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.68).
BP6
Variant 1-46405702-C-G is Benign according to our data. Variant chr1-46405702-C-G is described in ClinVar as [Benign]. Clinvar id is 788507.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-1.09 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00548 (835/152350) while in subpopulation AFR AF= 0.019 (791/41586). AF 95% confidence interval is 0.0179. There are 9 homozygotes in gnomad4. There are 401 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 9 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
FAAH | NM_001441.3 | c.693C>G | p.Pro231= | synonymous_variant | 5/15 | ENST00000243167.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
FAAH | ENST00000243167.9 | c.693C>G | p.Pro231= | synonymous_variant | 5/15 | 1 | NM_001441.3 | P1 | |
FAAH | ENST00000468718.5 | n.682C>G | non_coding_transcript_exon_variant | 5/5 | 3 | ||||
FAAH | ENST00000493735.5 | n.671C>G | non_coding_transcript_exon_variant | 5/8 | 5 | ||||
FAAH | ENST00000484697.5 | upstream_gene_variant | 1 |
Frequencies
GnomAD3 genomes AF: 0.00548 AC: 834AN: 152232Hom.: 9 Cov.: 33
GnomAD3 genomes
AF:
AC:
834
AN:
152232
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00140 AC: 350AN: 250888Hom.: 3 AF XY: 0.000994 AC XY: 135AN XY: 135824
GnomAD3 exomes
AF:
AC:
350
AN:
250888
Hom.:
AF XY:
AC XY:
135
AN XY:
135824
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000521 AC: 762AN: 1461252Hom.: 5 Cov.: 58 AF XY: 0.000446 AC XY: 324AN XY: 726934
GnomAD4 exome
AF:
AC:
762
AN:
1461252
Hom.:
Cov.:
58
AF XY:
AC XY:
324
AN XY:
726934
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00548 AC: 835AN: 152350Hom.: 9 Cov.: 33 AF XY: 0.00538 AC XY: 401AN XY: 74502
GnomAD4 genome
AF:
AC:
835
AN:
152350
Hom.:
Cov.:
33
AF XY:
AC XY:
401
AN XY:
74502
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 31, 2019 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at